2.30
Schlusskurs vom Vortag:
$2.38
Offen:
$2.315
24-Stunden-Volumen:
5,822
Relative Volume:
0.00
Marktkapitalisierung:
$15.88M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.72M
KGV:
-0.8714
EPS:
-2.6394
Netto-Cashflow:
$-6.25M
1W Leistung:
+1.72%
1M Leistung:
-8.00%
6M Leistung:
-38.83%
1J Leistung:
-47.49%
Edesa Biotech Inc Stock (EDSA) Company Profile
Firmenname
Edesa Biotech Inc
Sektor
Branche
Telefon
(905) 475-1234
Adresse
100 SPY COURT, MARKHAM, ON
Vergleichen Sie EDSA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
EDSA
Edesa Biotech Inc
|
2.30 | 15.88M | 0 | -7.72M | -6.25M | -2.6394 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
489.42 | 128.67B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
585.35 | 60.99B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
599.91 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
236.34 | 29.89B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
253.34 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Edesa Biotech Inc Aktie (EDSA) Neueste Nachrichten
Healthcare Veteran Returns to NeuPath as President, Armed with Ambitious Expansion Plan - Stock Titan
Edesa Biotech secures $15 million for clinical program - MSN
Edesa Biotech (NASDAQ:EDSA) and Earth Science Tech (OTCMKTS:ETST) Head-To-Head Review - Defense World
Edesa Biotech says Peter Weiler to succeed Stephen Lemieux as CFO - MSN
Nuvectis Pharma (NASDAQ:NVCT) and Edesa Biotech (NASDAQ:EDSA) Critical Analysis - Defense World
Edesa Biotech Announces Chief Financial Officer Transition - GlobeNewswire
Edesa Biotech announces CFO transition - MSN
Edesa Biotech names Peter Weiler as new CFO By Investing.com - Investing.com South Africa
Edesa Biotech (EDSA) Shares Drop After New CFO Announcement - GuruFocus
Edesa Biotech Appoints New CFO Amid Leadership Change - TipRanks
Edesa Biotech names Peter Weiler as new CFO - Investing.com
Edesa Biotech Hires Peter Weiler From Exzell Pharma to be New CFO - marketscreener.com
Edesa Biotech, Inc. Announces Chief Financial Officer Changes, Effective May 1, 2025 - MarketScreener
HC Wainwright Comments on Edesa Biotech Q2 Earnings - Defense World
HC Wainwright Reiterates “Buy” Rating for Edesa Biotech (NASDAQ:EDSA) - Defense World
H.C. Wainwright maintains $21 target on Edesa Biotech shares By Investing.com - Investing.com Australia
H.C. Wainwright maintains $21 target on Edesa Biotech shares - Investing.com India
Hidden Gems: 5 Stocks Under $10 With Massive Growth Potential - The Globe and Mail
Edesa Biotech completes US$15 million private placement - Fasken
You Won't Believe What Nvidia CEO Jensen Huang Just Said - The Globe and Mail
Edesa Biotech files to sell 7.81M common shares for holders - MSN
Nvidia Stock Isn’t So Magnificent Anymore. Is It Time to Sell Shares Now? - The Globe and Mail
Zacks Small Cap Boosts Earnings Estimates for Edesa Biotech - Defense World
EDSA: Raises 15 Million to Advance EB06 - Smartkarma
EDSA: Raises $15 Million to Advance EB06… - Yahoo Finance
Biotech Stocks To Keep An Eye OnFebruary 13th - MarketBeat
Biotech Stocks To Keep An Eye On – February 13th - Defense World
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results - GlobeNewswire
Edesa Biotech Advances Vitiligo Treatment Amidst Solid Financial Backing - TipRanks
Edesa Biotech Inc. (EDSA) reports earnings - Quartz
Edesa Biotech Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Edesa Biotech, Inc. SEC 10-Q Report - TradingView
Edesa Biotech Reports Q1 2025 Financial Results and Updates on EB06 Development for Vitiligo Treatment - Nasdaq
Edesa's Q1 Report Reveals Major Vitiligo Drug Progress: $15M Cash Injection Fuels FDA Push - StockTitan
US Penny Stocks To Watch In February 2025 - Simply Wall St
Edesa Biotech secures $15 million for clinical program By Investing.com - Investing.com Nigeria
Novartis to acquire Anthos Therapeutics for up to $3.1 billion - MSN
Edesa Biotech, Inc. announced that it has received $14.999992 million in funding from Velan Capital Investment Management LP and another investor - Marketscreener.com
H: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
Edesa Biotech Inc (EDSA) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Dow Jumps Over 100 Points; Deere Posts Upbeat Earnings - Benzinga
Stock market news: Moleculin Biotech +583.33%, Cloudastructure +105.68% among top gainers during midday trading - Business Upturn
Nasdaq Surges 150 Points; Cisco Earnings Top Views - Benzinga
Edesa Biotech shares jump on $15M private placement - MSN
Edesa Biotech (EDSA) Sees Sharp Stock Increase After Equity News - Stocks Telegraph
Stock market today: Moleculin Biotech +388.10%, Alpha Modus Holdings +156.52% among top gainers in early trading - Business Upturn
MAXONA Pharmaceuticals Completes Phase 1 Trials for Breakthrough Pain Therapy - MSN
US Stocks Edge Higher; Producer Prices Increase In January - Benzinga
Finanzdaten der Edesa Biotech Inc-Aktie (EDSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):